Home > Insider Trading > Filing (0001181431-14-029918)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1302573	Oncomed Pharmaceuticals Inc	OMED	Pharmaceutical Preparations (2834)	383572512

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270734	Deepika Pakianathan	C/O Delphi Ventures 3000 Sand Hill Road, #1-135 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-19	12,425	$18.89	1,924,570	No	4	P	Indirect	By Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-08-19	116	$18.89	18,310	No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.
Common Stock	Acquisiton	2014-08-20	45,630	$19.00	1,970,200	No	4	P	Indirect	By Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-08-20	429	$19.00	18,739	No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.
Common Stock	Acquisiton	2014-08-21	21,402	$18.98	1,991,602	No	4	P	Indirect	By Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-08-21	201	$18.98	18,940	No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Delphi Ventures VIII, L.P.
No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.
No	4	P	Indirect	By Delphi Ventures VIII, L.P.
No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.
No	4	P	Indirect	By Delphi Ventures VIII, L.P.
No	4	P	Indirect	By Delphi BioInvestments VIII, L.P.

Footnotes

The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP VIII"), the general partner of each of Delphi Ventures VIII, L.P. and Delphi BioInvestments VIII, L.P. (collectively, the "Delphi VIII Funds"). As a managing member of DMP VIII, the Reporting Person shares voting and dispositive power over the shares held by the Delphi VIII Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Delphi VIII Funds, except to the extent of her proportionate pecuniary interest therein.